Outcomes Seem No Worse With Stereotactic RT for Brain Mets in SCLC

THURSDAY, June 2, 2022 (HealthDay News) -- For patients with small cell lung cancer (SCLC) with intracranial metastatic disease (IMD), outcomes appear to be no worse with stereotactic radiosurgery (SRS) compared with whole brain radiotherapy (WBRT), according to research published online May 26 in The Lancet Oncology.
Karolina Gaebe, from the University of Toronto, and colleagues conducted a systematic review and meta-analysis to examine the efficacy of SRS for IMD treatment in patients with SCLC. Thirty-one studies were eligible for inclusion, and seven were included in the meta-analysis.
The researchers found that overall survival was longer following SRS than WBRT with or without SRS boost (hazard ratio, 0.85; 95 percent confidence interval, 0.75 to 0.97) or WBRT alone (hazard ratio, 0.77; 95 percent confidence interval, 0.72 to 0.83), but not compared with WBRT plus SRS boost (hazard ratio, 1.17; 95 percent confidence interval, 0.78 to 1.75). The pooled median overall survival from SRS was 8.99 months using single-arm studies. Considerable between-study heterogeneity was seen when pooled among all comparative studies.
"Our findings suggest no significant disadvantage in outcomes following SRS compared with WBRT in this cohort," the authors write. "Future prospective controlled trials are needed to investigate the impact of IMD burden and differences in intracranial control between WBRT and SRS in this historically excluded population."
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
¿Va a viajar al extranjero? Siga esta lista de comprobación de salud
DOMINGO, 8 de mayo de 2022 (HealthDay News) -- A medida que se acerca el verano,...
Unas infusiones de lidocaína podrían aliviar las migrañas difíciles de tratar
JUEVES, 26 de mayo de 2022 (HealthDay News) -- Una infusión intravenosa (IV)...
Redo Transcatheter Aortic Valve Replacement Safe, Effective
MONDAY, Sept. 11, 2023 (HealthDay News) -- Redo transcatheter aortic valve...
Los perros de compañía pueden avisar a sus amos de las convulsiones epilépticas
MIÉRCOLES, 8 de septiembre de 2021 (HealthDay News) -- Siéntate. Búscalo....
